Changrong Shi
- Biomedical Engineering top 2%
- Materials Chemistry top 10%
- Molecular Biology
- Biomaterials top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Xianzhong ZhangXiaohong ChenTing LiuManli SongXiaoyuan ChenZhide GuoZijian ZhouRongqiang Zhuang
- Topics
- Nanoplatforms for cancer theranostics (16 papers)Radiopharmaceutical Chemistry and Applications (8 papers)Medical Imaging Techniques and Applications (7 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Changrong Shi
51 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Biomedical Engineering 1.4k
- Materials Chemistry 697
- Molecular Biology 672
- Biomaterials 540
- Pulmonary and Respiratory Medicine 525
Countries citing papers authored by Changrong Shi
This map shows the geographic impact of Changrong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changrong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changrong Shi more than expected).
Fields of papers citing papers by Changrong Shi
This network shows the impact of papers produced by Changrong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changrong Shi. The network helps show where Changrong Shi may publish in the future.
Co-authorship network of co-authors of Changrong Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Changrong Shi. A scholar is included among the top collaborators of Changrong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changrong Shi. Changrong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 44 | |
| 10 | 1 | |
| 11 | 6 | |
| 12 | 9 | |
| 13 | 78 | |
| 14 | 1 | |
| 15 | 17 | |
| 16 | 27 | |
| 17 | 4 | |
| 18 | 25 | |
| 19 | Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumorsbreakdown → | 548 |
| 20 | 28 |
About Changrong Shi
Changrong Shi is a scholar working on Biomaterials, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Medical Imaging Techniques and Applications (7 papers). The work is most often cited by research in Biomaterials (540 citations), Biomedical Engineering (1.4k citations) and Cancer Research (328 citations). Changrong Shi has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Xianzhong Zhang, Xiaohong Chen, Ting Liu, Manli Song, Xiaoyuan Chen, Zhide Guo, Zijian Zhou, Ting Liu, Rongqiang Zhuang and Fantian Zeng. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.